Enhanced C30 carotenoid production in Bacillus subtilis by systematic overexpression of MEP pathway genes
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605503168 | ||
| 003 | CHVBK | ||
| 005 | 20210128100609.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150701xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s00253-015-6531-3 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s00253-015-6531-3 | ||
| 245 | 0 | 0 | |a Enhanced C30 carotenoid production in Bacillus subtilis by systematic overexpression of MEP pathway genes |h [Elektronische Daten] |c [Dan Xue, Ingy Abdallah, Ilse de Haan, Mark Sibbald, Wim Quax] |
| 520 | 3 | |a Creating novel biosynthetic pathways and modulating the synthesis of important compounds are one of the hallmarks of synthetic biology. Understanding the key parameters controlling the flux of chemicals throughout a metabolic pathway is one of the challenges ahead. Isoprenoids are the most functionally and structurally diverse group of natural products from which numerous medicines and relevant fine chemicals are derived. The well-characterized and broadly used production organism Bacillus subtilis forms an ideal background for creating and studying novel synthetic routes. In comparison to other bacteria, B. subtilis emits the volatile compound isoprene, the smallest representative of isoprenoids, in high concentrations and thus represents an interesting starting point for an isoprenoid cell factory. In this study, the effect of systematic overexpression of the genes involved in the methylerythritol phosphate (MEP) pathway on isoprenoid production in B. subtilis was investigated. B. subtilis strains harboring a plasmid containing C30 carotenoid synthetic genes, crtM and crtN, were combined with pHCMC04G plasmids carrying various synthetic operons of the MEP pathway genes. The levels of produced carotenoids, diaponeurosporene and diapolycopene, were used as indication of the role of the various enzymes on the flux of the MEP pathway. It was shown that the production of carotenoids can be increased significantly by overexpressing the MEP pathway enzymes. More broadly, the strains developed in this study can be used as a starting point for various isoprenoid cell factories. | |
| 540 | |a The Author(s), 2015 | ||
| 690 | 7 | |a Terpenoids |2 nationallicence | |
| 690 | 7 | |a MEP |2 nationallicence | |
| 690 | 7 | |a Bacillus subtilis |2 nationallicence | |
| 690 | 7 | |a Isoprene |2 nationallicence | |
| 690 | 7 | |a Carotenoid |2 nationallicence | |
| 700 | 1 | |a Xue |D Dan |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Abdallah |D Ingy |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a de Haan |D Ilse |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Sibbald |D Mark |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Quax |D Wim |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | |
| 773 | 0 | |t Applied Microbiology and Biotechnology |d Springer Berlin Heidelberg |g 99/14(2015-07-01), 5907-5915 |x 0175-7598 |q 99:14<5907 |1 2015 |2 99 |o 253 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00253-015-6531-3 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s00253-015-6531-3 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Xue |D Dan |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Abdallah |D Ingy |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a de Haan |D Ilse |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Sibbald |D Mark |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Quax |D Wim |u Department of Pharmaceutical Biology, GRIP, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Applied Microbiology and Biotechnology |d Springer Berlin Heidelberg |g 99/14(2015-07-01), 5907-5915 |x 0175-7598 |q 99:14<5907 |1 2015 |2 99 |o 253 | ||